Quinoxalinedione leukotriene release inhibitors
US4486432A · kind A · utility
1Cited by
1References
12Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Sep 30, 1982 |
| Grant date | Dec 4, 1984 |
| Priority date | — |
| Expiry date | Sep 30, 2002 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P37/08
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
This invention provides for novel quinoxalinedione derivatives, the use of quinoxalinedione derivatives in treating animals suffering from immediate hypersensitivity reactions and conditions characterized by excessive release of leukotrienes, and formulations of the quinoxalinedione derivatives.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.